Towards quicker, more accessible and less expensive diagnosis and monitoring of a rare childhood genetic disease

The project led by Dr. Ignacio Alfonso, of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), in collaboration with the Vall d’Hebron Hospital, is one of those selected in the CaixaResearch Validate 2022 call. The researchers have created a new diagnostic and monitoring tool for the cystinosis that would allow preventive screening and more effective monitoring of the disease and that would be much less disruptive to the life of the patient and his family.

The BACDA project has been one of the 15 projects selected from among the 110 presented in the CaixaResearch Validate 2022 call, of the “la Caixa” Foundation. These are cutting-edge biomedical research projects in Spain and Portugal that are in their initial stages and which the entity wants to support in order to accelerate their arrival on the market for patients. Those chosen receive up to 100,000 euros from the program to validate their technologies and design a roadmap for their valorization.